accession	library_ID	title	library_strategy	library_source	library_selection	library_layout	platform	instrument_model	design_description	filetype	filename
SAMN34331317	E177_03_100_2_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_100_2_1_R1.fq.gz
SAMN34331318	E177_03_100_2_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_100_2_1_R1.fq.gz
SAMN34331267	E177_03_100_2_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_100_2_1_R1.fq.gz
SAMN34331278	E177_03_100_2_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_100_2_1_R1.fq.gz
SAMN34331319	E177_03_100_2_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_100_2_1_R1.fq.gz
SAMN34331320	E177_03_100_2_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_100_2_1_R1.fq.gz
SAMN34331321	E177_03_100_2_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_100_2_1_R1.fq.gz
SAMN34331322	E177_03_100_2_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_100_2_1_R1.fq.gz
SAMN34331323	E177_03_100_2_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_100_2_1_R1.fq.gz
SAMN34331324	E177_03_100_2_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_100_2_1_R1.fq.gz
SAMN34331325	E177_03_100_2_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_100_2_1_R1.fq.gz
SAMN34331326	E177_03_100_2_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_100_2_1_R1.fq.gz
SAMN34331327	E177_03_100_2_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_100_2_1_R1.fq.gz
SAMN34331328	E177_03_100_2_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_100_2_1_R1.fq.gz
SAMN34331278	E177_03_100_2_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_100_2_1_R1.fq.gz
SAMN34331245	E177_04_100_2_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_100_2_2_R1.fq.gz
SAMN34331329	E177_04_100_2_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_100_2_2_R1.fq.gz
SAMN34331330	E177_04_100_2_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_100_2_2_R1.fq.gz
SAMN34331331	E177_04_100_2_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_100_2_2_R1.fq.gz
SAMN34331332	E177_04_100_2_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_100_2_2_R1.fq.gz
SAMN34331333	E177_04_100_2_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_100_2_2_R1.fq.gz
SAMN34331334	E177_04_100_2_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_100_2_2_R1.fq.gz
SAMN34331335	E177_04_100_2_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_100_2_2_R1.fq.gz
SAMN34331336	E177_04_100_2_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_100_2_2_R1.fq.gz
SAMN34331337	E177_04_100_2_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_100_2_2_R1.fq.gz
SAMN34331338	E177_04_100_2_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_100_2_2_R1.fq.gz
SAMN34331245	E177_04_100_2_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_100_2_2_R1.fq.gz
SAMN34331256	E177_04_100_2_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_100_2_2_R1.fq.gz
SAMN34331339	E177_04_100_2_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_100_2_2_R1.fq.gz
SAMN34331340	E177_04_100_2_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_100_2_2_R1.fq.gz
SAMN34331341	E177_04_100_2_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_100_2_2_R1.fq.gz
SAMN34331342	E177_04_100_2_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_100_2_2_R1.fq.gz
SAMN34331343	E177_04_100_2_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_100_2_2_R1.fq.gz
SAMN34331344	E177_04_100_2_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_100_2_2_R1.fq.gz
SAMN34331345	E177_04_100_2_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_100_2_2_R1.fq.gz
SAMN34331346	E177_04_100_2_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_100_2_2_R1.fq.gz
SAMN34331347	E177_04_100_2_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_100_2_2_R1.fq.gz
SAMN34331348	E177_04_100_2_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_100_2_2_R1.fq.gz
SAMN34331256	E177_04_100_2_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_100_2_2_R1.fq.gz
SAMN34331267	E177_04_100_2_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_100_2_2_R1.fq.gz
SAMN34331349	E177_04_100_2_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_100_2_2_R1.fq.gz
SAMN34331350	E177_04_100_2_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_100_2_2_R1.fq.gz
SAMN34331351	E177_04_100_2_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_100_2_2_R1.fq.gz
SAMN34331352	E177_04_100_2_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_100_2_2_R1.fq.gz
SAMN34331353	E177_04_100_2_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_100_2_2_R1.fq.gz
SAMN34331354	E177_04_100_2_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_100_2_2_R1.fq.gz
SAMN34331355	E177_04_100_2_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_100_2_2_R1.fq.gz
SAMN34331356	E177_04_100_2_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_100_2_2_R1.fq.gz
SAMN34331357	E177_04_100_2_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_100_2_2_R1.fq.gz
SAMN34331358	E177_04_100_2_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_100_2_2_R1.fq.gz
SAMN34331267	E177_04_100_2_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_100_2_2_R1.fq.gz
SAMN34331278	E177_04_100_2_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_100_2_2_R1.fq.gz
SAMN34331359	E177_04_100_2_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_100_2_2_R1.fq.gz
SAMN34331360	E177_04_100_2_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_100_2_2_R1.fq.gz
SAMN34331361	E177_04_100_2_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_100_2_2_R1.fq.gz
SAMN34331362	E177_04_100_2_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_100_2_2_R1.fq.gz
SAMN34331363	E177_04_100_2_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_100_2_2_R1.fq.gz
SAMN34331364	E177_04_100_2_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_100_2_2_R1.fq.gz
SAMN34331365	E177_04_100_2_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_100_2_2_R1.fq.gz
SAMN34331366	E177_04_100_2_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_100_2_2_R1.fq.gz
SAMN34331367	E177_04_100_2_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_100_2_2_R1.fq.gz
SAMN34331368	E177_04_100_2_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_100_2_2_R1.fq.gz
SAMN34331278	E177_04_100_2_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_100_2_2_R1.fq.gz
SAMN34331245	E177_04_100_2_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_100_2_2_R1.fq.gz
SAMN34331369	E177_04_100_2_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_100_2_2_R1.fq.gz
SAMN34331370	E177_04_100_2_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_100_2_2_R1.fq.gz
SAMN34331371	E177_04_100_2_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_100_2_2_R1.fq.gz
SAMN34331372	E177_04_100_2_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_100_2_2_R1.fq.gz
SAMN34331373	E177_04_100_2_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_100_2_2_R1.fq.gz
SAMN34331374	E177_04_100_2_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_100_2_2_R1.fq.gz
SAMN34331375	E177_04_100_2_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_100_2_2_R1.fq.gz
SAMN34331376	E177_04_100_2_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_100_2_2_R1.fq.gz
SAMN34331377	E177_04_100_2_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_100_2_2_R1.fq.gz
SAMN34331378	E177_04_100_2_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_100_2_2_R1.fq.gz
SAMN34331245	E177_04_100_2_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_100_2_2_R1.fq.gz
SAMN34331256	E177_04_100_2_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_100_2_2_R1.fq.gz
SAMN34331379	E177_04_100_2_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_100_2_2_R1.fq.gz
SAMN34331380	E177_04_100_2_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_100_2_2_R1.fq.gz
SAMN34331381	E177_04_100_2_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_100_2_2_R1.fq.gz
SAMN34331382	E177_04_100_2_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_100_2_2_R1.fq.gz
SAMN34331383	E177_04_100_2_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_100_2_2_R1.fq.gz
SAMN34331384	E177_04_100_2_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_100_2_2_R1.fq.gz
SAMN34331385	E177_04_100_2_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_100_2_2_R1.fq.gz
SAMN34331386	E177_04_100_2_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_100_2_2_R1.fq.gz
SAMN34331387	E177_04_100_2_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_100_2_2_R1.fq.gz
SAMN34331388	E177_04_100_2_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_100_2_2_R1.fq.gz
SAMN34331256	E177_04_100_2_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_100_2_2_R1.fq.gz
SAMN34331267	E177_04_100_2_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_100_2_2_R1.fq.gz
SAMN34331389	E177_04_100_2_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_100_2_2_R1.fq.gz
SAMN34331390	E177_04_100_2_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_100_2_2_R1.fq.gz
SAMN34331391	E177_04_100_2_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_100_2_2_R1.fq.gz
SAMN34331392	E177_04_100_2_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_100_2_2_R1.fq.gz
SAMN34331393	E177_04_100_2_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_100_2_2_R1.fq.gz
SAMN34331394	E177_04_100_2_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_100_2_2_R1.fq.gz
SAMN34331395	E177_04_100_2_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_100_2_2_R1.fq.gz
SAMN34331396	E177_04_100_2_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_100_2_2_R1.fq.gz
SAMN34331397	E177_04_100_2_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_100_2_2_R1.fq.gz
SAMN34331398	E177_04_100_2_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_100_2_2_R1.fq.gz
SAMN34331267	E177_04_100_2_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_100_2_2_R1.fq.gz
SAMN34331278	E177_04_100_2_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_100_2_2_R1.fq.gz
SAMN34331399	E177_04_100_2_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_100_2_2_R1.fq.gz
SAMN34331400	E177_04_100_2_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_100_2_2_R1.fq.gz
SAMN34331401	E177_04_100_2_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_100_2_2_R1.fq.gz
SAMN34331402	E177_04_100_2_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_100_2_2_R1.fq.gz
SAMN34331403	E177_04_100_2_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_100_2_2_R1.fq.gz
SAMN34331404	E177_04_100_2_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_100_2_2_R1.fq.gz
SAMN34331405	E177_04_100_2_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_100_2_2_R1.fq.gz
SAMN34331406	E177_04_100_2_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_100_2_2_R1.fq.gz
SAMN34331407	E177_04_100_2_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_100_2_2_R1.fq.gz
SAMN34331408	E177_04_100_2_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_100_2_2_R1.fq.gz
SAMN34331278	E177_04_100_2_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_100_2_2_R1.fq.gz
SAMN34331245	E177_05_100_3_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_100_3_1_R1.fq.gz
SAMN34331246	E177_05_100_3_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_100_3_1_R1.fq.gz
SAMN34331247	E177_05_100_3_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_100_3_1_R1.fq.gz
SAMN34331248	E177_05_100_3_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_100_3_1_R1.fq.gz
SAMN34331249	E177_05_100_3_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_100_3_1_R1.fq.gz
SAMN34331250	E177_05_100_3_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_100_3_1_R1.fq.gz
SAMN34331251	E177_05_100_3_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_100_3_1_R1.fq.gz
SAMN34331252	E177_05_100_3_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_100_3_1_R1.fq.gz
SAMN34331253	E177_05_100_3_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_100_3_1_R1.fq.gz
SAMN34331254	E177_05_100_3_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_100_3_1_R1.fq.gz
SAMN34331255	E177_05_100_3_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_100_3_1_R1.fq.gz
SAMN34331245	E177_05_100_3_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_100_3_1_R1.fq.gz
SAMN34331256	E177_05_100_3_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_100_3_1_R1.fq.gz
SAMN34331257	E177_05_100_3_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_100_3_1_R1.fq.gz
SAMN34331258	E177_05_100_3_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_100_3_1_R1.fq.gz
SAMN34331259	E177_05_100_3_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_100_3_1_R1.fq.gz
SAMN34331260	E177_05_100_3_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_100_3_1_R1.fq.gz
SAMN34331261	E177_05_100_3_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_100_3_1_R1.fq.gz
SAMN34331262	E177_05_100_3_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_100_3_1_R1.fq.gz
SAMN34331263	E177_05_100_3_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_100_3_1_R1.fq.gz
SAMN34331264	E177_05_100_3_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_100_3_1_R1.fq.gz
SAMN34331265	E177_05_100_3_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_100_3_1_R1.fq.gz
SAMN34331266	E177_05_100_3_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_100_3_1_R1.fq.gz
SAMN34331256	E177_05_100_3_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_100_3_1_R1.fq.gz
SAMN34331267	E177_05_100_3_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_100_3_1_R1.fq.gz
SAMN34331268	E177_05_100_3_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_100_3_1_R1.fq.gz
SAMN34331269	E177_05_100_3_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_100_3_1_R1.fq.gz
SAMN34331270	E177_05_100_3_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_100_3_1_R1.fq.gz
SAMN34331271	E177_05_100_3_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_100_3_1_R1.fq.gz
SAMN34331272	E177_05_100_3_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_100_3_1_R1.fq.gz
SAMN34331273	E177_05_100_3_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_100_3_1_R1.fq.gz
SAMN34331274	E177_05_100_3_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_100_3_1_R1.fq.gz
SAMN34331275	E177_05_100_3_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_100_3_1_R1.fq.gz
SAMN34331276	E177_05_100_3_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_100_3_1_R1.fq.gz
SAMN34331277	E177_05_100_3_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_100_3_1_R1.fq.gz
SAMN34331267	E177_05_100_3_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_100_3_1_R1.fq.gz
SAMN34331278	E177_05_100_3_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_100_3_1_R1.fq.gz
SAMN34331279	E177_05_100_3_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_100_3_1_R1.fq.gz
SAMN34331280	E177_05_100_3_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_100_3_1_R1.fq.gz
SAMN34331281	E177_05_100_3_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_100_3_1_R1.fq.gz
SAMN34331282	E177_05_100_3_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_100_3_1_R1.fq.gz
SAMN34331283	E177_05_100_3_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_100_3_1_R1.fq.gz
SAMN34331284	E177_05_100_3_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_100_3_1_R1.fq.gz
SAMN34331285	E177_05_100_3_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_100_3_1_R1.fq.gz
SAMN34331286	E177_05_100_3_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_100_3_1_R1.fq.gz
SAMN34331287	E177_05_100_3_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_100_3_1_R1.fq.gz
SAMN34331288	E177_05_100_3_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_100_3_1_R1.fq.gz
SAMN34331278	E177_05_100_3_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_100_3_1_R1.fq.gz
SAMN34331245	E177_05_100_3_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_100_3_1_R1.fq.gz
SAMN34331289	E177_05_100_3_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_100_3_1_R1.fq.gz
SAMN34331290	E177_05_100_3_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_100_3_1_R1.fq.gz
SAMN34331291	E177_05_100_3_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_100_3_1_R1.fq.gz
SAMN34331292	E177_05_100_3_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_100_3_1_R1.fq.gz
SAMN34331293	E177_05_100_3_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_100_3_1_R1.fq.gz
SAMN34331294	E177_05_100_3_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_100_3_1_R1.fq.gz
SAMN34331295	E177_05_100_3_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_100_3_1_R1.fq.gz
SAMN34331296	E177_05_100_3_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_100_3_1_R1.fq.gz
SAMN34331297	E177_05_100_3_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_100_3_1_R1.fq.gz
SAMN34331298	E177_05_100_3_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_100_3_1_R1.fq.gz
SAMN34331245	E177_05_100_3_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_100_3_1_R1.fq.gz
SAMN34331256	E177_05_100_3_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_100_3_1_R1.fq.gz
SAMN34331299	E177_05_100_3_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_100_3_1_R1.fq.gz
SAMN34331300	E177_05_100_3_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_100_3_1_R1.fq.gz
SAMN34331301	E177_05_100_3_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_100_3_1_R1.fq.gz
SAMN34331302	E177_05_100_3_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_100_3_1_R1.fq.gz
SAMN34331303	E177_05_100_3_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_100_3_1_R1.fq.gz
SAMN34331304	E177_05_100_3_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_100_3_1_R1.fq.gz
SAMN34331305	E177_05_100_3_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_100_3_1_R1.fq.gz
SAMN34331306	E177_05_100_3_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_100_3_1_R1.fq.gz
SAMN34331307	E177_05_100_3_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_100_3_1_R1.fq.gz
SAMN34331308	E177_05_100_3_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_100_3_1_R1.fq.gz
SAMN34331256	E177_05_100_3_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_100_3_1_R1.fq.gz
SAMN34331267	E177_05_100_3_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_100_3_1_R1.fq.gz
SAMN34331309	E177_05_100_3_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_100_3_1_R1.fq.gz
SAMN34331310	E177_05_100_3_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_100_3_1_R1.fq.gz
SAMN34331311	E177_05_100_3_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_100_3_1_R1.fq.gz
SAMN34331312	E177_05_100_3_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_100_3_1_R1.fq.gz
SAMN34331313	E177_05_100_3_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_100_3_1_R1.fq.gz
SAMN34331314	E177_05_100_3_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_100_3_1_R1.fq.gz
SAMN34331315	E177_05_100_3_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_100_3_1_R1.fq.gz
SAMN34331316	E177_05_100_3_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_100_3_1_R1.fq.gz
SAMN34331317	E177_05_100_3_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_100_3_1_R1.fq.gz
SAMN34331318	E177_05_100_3_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_100_3_1_R1.fq.gz
SAMN34331267	E177_05_100_3_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_100_3_1_R1.fq.gz
SAMN34331278	E177_05_100_3_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_100_3_1_R1.fq.gz
SAMN34331319	E177_05_100_3_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_100_3_1_R1.fq.gz
SAMN34331320	E177_05_100_3_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_100_3_1_R1.fq.gz
SAMN34331321	E177_05_100_3_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_100_3_1_R1.fq.gz
SAMN34331322	E177_05_100_3_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_100_3_1_R1.fq.gz
SAMN34331323	E177_05_100_3_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_100_3_1_R1.fq.gz
SAMN34331324	E177_05_100_3_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_100_3_1_R1.fq.gz
SAMN34331325	E177_05_100_3_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_100_3_1_R1.fq.gz
SAMN34331326	E177_05_100_3_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_100_3_1_R1.fq.gz
SAMN34331327	E177_05_100_3_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_100_3_1_R1.fq.gz
SAMN34331328	E177_05_100_3_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_100_3_1_R1.fq.gz
SAMN34331278	E177_05_100_3_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_100_3_1_R1.fq.gz
SAMN34331245	E177_06_100_3_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_100_3_2_R1.fq.gz
SAMN34331329	E177_06_100_3_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_100_3_2_R1.fq.gz
SAMN34331330	E177_06_100_3_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_100_3_2_R1.fq.gz
SAMN34331331	E177_06_100_3_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_100_3_2_R1.fq.gz
SAMN34331332	E177_06_100_3_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_100_3_2_R1.fq.gz
SAMN34331333	E177_06_100_3_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_100_3_2_R1.fq.gz
SAMN34331334	E177_06_100_3_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_100_3_2_R1.fq.gz
SAMN34331335	E177_06_100_3_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_100_3_2_R1.fq.gz
SAMN34331336	E177_06_100_3_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_100_3_2_R1.fq.gz
SAMN34331337	E177_06_100_3_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_100_3_2_R1.fq.gz
SAMN34331338	E177_06_100_3_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_100_3_2_R1.fq.gz
SAMN34331245	E177_06_100_3_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_100_3_2_R1.fq.gz
SAMN34331256	E177_06_100_3_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_100_3_2_R1.fq.gz
SAMN34331339	E177_06_100_3_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_100_3_2_R1.fq.gz
SAMN34331340	E177_06_100_3_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_100_3_2_R1.fq.gz
SAMN34331341	E177_06_100_3_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_100_3_2_R1.fq.gz
SAMN34331342	E177_06_100_3_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_100_3_2_R1.fq.gz
SAMN34331343	E177_06_100_3_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_100_3_2_R1.fq.gz
SAMN34331344	E177_06_100_3_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_100_3_2_R1.fq.gz
SAMN34331345	E177_06_100_3_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_100_3_2_R1.fq.gz
SAMN34331346	E177_06_100_3_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_100_3_2_R1.fq.gz
SAMN34331347	E177_06_100_3_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_100_3_2_R1.fq.gz
SAMN34331348	E177_06_100_3_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_100_3_2_R1.fq.gz
SAMN34331256	E177_06_100_3_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_100_3_2_R1.fq.gz
SAMN34331267	E177_06_100_3_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_100_3_2_R1.fq.gz
SAMN34331349	E177_06_100_3_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_100_3_2_R1.fq.gz
SAMN34331350	E177_06_100_3_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_100_3_2_R1.fq.gz
SAMN34331351	E177_06_100_3_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_100_3_2_R1.fq.gz
SAMN34331352	E177_06_100_3_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_100_3_2_R1.fq.gz
SAMN34331353	E177_06_100_3_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_100_3_2_R1.fq.gz
SAMN34331354	E177_06_100_3_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_100_3_2_R1.fq.gz
SAMN34331355	E177_06_100_3_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_100_3_2_R1.fq.gz
SAMN34331356	E177_06_100_3_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_100_3_2_R1.fq.gz
SAMN34331357	E177_06_100_3_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_100_3_2_R1.fq.gz
SAMN34331358	E177_06_100_3_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_100_3_2_R1.fq.gz
SAMN34331267	E177_06_100_3_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_100_3_2_R1.fq.gz
SAMN34331278	E177_06_100_3_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_100_3_2_R1.fq.gz
SAMN34331359	E177_06_100_3_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_100_3_2_R1.fq.gz
SAMN34331360	E177_06_100_3_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_100_3_2_R1.fq.gz
SAMN34331361	E177_06_100_3_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_100_3_2_R1.fq.gz
SAMN34331362	E177_06_100_3_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_100_3_2_R1.fq.gz
SAMN34331363	E177_06_100_3_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_100_3_2_R1.fq.gz
SAMN34331364	E177_06_100_3_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_100_3_2_R1.fq.gz
SAMN34331365	E177_06_100_3_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_100_3_2_R1.fq.gz
SAMN34331366	E177_06_100_3_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_100_3_2_R1.fq.gz
SAMN34331367	E177_06_100_3_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_100_3_2_R1.fq.gz
SAMN34331368	E177_06_100_3_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_100_3_2_R1.fq.gz
SAMN34331278	E177_06_100_3_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_100_3_2_R1.fq.gz
SAMN34331245	E177_06_100_3_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_100_3_2_R1.fq.gz
SAMN34331369	E177_06_100_3_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_100_3_2_R1.fq.gz
SAMN34331370	E177_06_100_3_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_100_3_2_R1.fq.gz
SAMN34331371	E177_06_100_3_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_100_3_2_R1.fq.gz
SAMN34331372	E177_06_100_3_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_100_3_2_R1.fq.gz
SAMN34331373	E177_06_100_3_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_100_3_2_R1.fq.gz
SAMN34331374	E177_06_100_3_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_100_3_2_R1.fq.gz
SAMN34331375	E177_06_100_3_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_100_3_2_R1.fq.gz
SAMN34331376	E177_06_100_3_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_100_3_2_R1.fq.gz
SAMN34331377	E177_06_100_3_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_100_3_2_R1.fq.gz
SAMN34331378	E177_06_100_3_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_100_3_2_R1.fq.gz
SAMN34331245	E177_06_100_3_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_100_3_2_R1.fq.gz
SAMN34331256	E177_06_100_3_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_100_3_2_R1.fq.gz
SAMN34331379	E177_06_100_3_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_100_3_2_R1.fq.gz
SAMN34331380	E177_06_100_3_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_100_3_2_R1.fq.gz
SAMN34331381	E177_06_100_3_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_100_3_2_R1.fq.gz
SAMN34331382	E177_06_100_3_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_100_3_2_R1.fq.gz
SAMN34331383	E177_06_100_3_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_100_3_2_R1.fq.gz
SAMN34331384	E177_06_100_3_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_100_3_2_R1.fq.gz
SAMN34331385	E177_06_100_3_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_100_3_2_R1.fq.gz
SAMN34331386	E177_06_100_3_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_100_3_2_R1.fq.gz
SAMN34331387	E177_06_100_3_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_100_3_2_R1.fq.gz
SAMN34331388	E177_06_100_3_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_100_3_2_R1.fq.gz
SAMN34331256	E177_06_100_3_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_100_3_2_R1.fq.gz
SAMN34331267	E177_06_100_3_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_100_3_2_R1.fq.gz
SAMN34331389	E177_06_100_3_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_100_3_2_R1.fq.gz
SAMN34331390	E177_06_100_3_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_100_3_2_R1.fq.gz
SAMN34331391	E177_06_100_3_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_100_3_2_R1.fq.gz
SAMN34331392	E177_06_100_3_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_100_3_2_R1.fq.gz
SAMN34331393	E177_06_100_3_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_100_3_2_R1.fq.gz
SAMN34331394	E177_06_100_3_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_100_3_2_R1.fq.gz
SAMN34331395	E177_06_100_3_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_100_3_2_R1.fq.gz
SAMN34331396	E177_06_100_3_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_100_3_2_R1.fq.gz
SAMN34331397	E177_06_100_3_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_100_3_2_R1.fq.gz
SAMN34331398	E177_06_100_3_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_100_3_2_R1.fq.gz
SAMN34331267	E177_06_100_3_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_100_3_2_R1.fq.gz
SAMN34331278	E177_06_100_3_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_100_3_2_R1.fq.gz
SAMN34331399	E177_06_100_3_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_100_3_2_R1.fq.gz
SAMN34331400	E177_06_100_3_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_100_3_2_R1.fq.gz
SAMN34331401	E177_06_100_3_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_100_3_2_R1.fq.gz
SAMN34331402	E177_06_100_3_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_100_3_2_R1.fq.gz
SAMN34331403	E177_06_100_3_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_100_3_2_R1.fq.gz
SAMN34331404	E177_06_100_3_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_100_3_2_R1.fq.gz
SAMN34331405	E177_06_100_3_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_100_3_2_R1.fq.gz
SAMN34331406	E177_06_100_3_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_100_3_2_R1.fq.gz
SAMN34331407	E177_06_100_3_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_100_3_2_R1.fq.gz
SAMN34331408	E177_06_100_3_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_100_3_2_R1.fq.gz
SAMN34331278	E177_06_100_3_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_100_3_2_R1.fq.gz
SAMN34331245	E177_07_1_1_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_1_1_1_R1.fq.gz
SAMN34331409	E177_07_1_1_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_1_1_1_R1.fq.gz
SAMN34331410	E177_07_1_1_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_1_1_1_R1.fq.gz
SAMN34331411	E177_07_1_1_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_1_1_1_R1.fq.gz
SAMN34331412	E177_07_1_1_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_1_1_1_R1.fq.gz
SAMN34331413	E177_07_1_1_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_1_1_1_R1.fq.gz
SAMN34331414	E177_07_1_1_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_1_1_1_R1.fq.gz
SAMN34331415	E177_07_1_1_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_1_1_1_R1.fq.gz
SAMN34331416	E177_07_1_1_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_1_1_1_R1.fq.gz
SAMN34331417	E177_07_1_1_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_1_1_1_R1.fq.gz
SAMN34331418	E177_07_1_1_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_1_1_1_R1.fq.gz
SAMN34331245	E177_07_1_1_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_1_1_1_R1.fq.gz
SAMN34331256	E177_07_1_1_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_1_1_1_R1.fq.gz
SAMN34331419	E177_07_1_1_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_1_1_1_R1.fq.gz
SAMN34331420	E177_07_1_1_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_1_1_1_R1.fq.gz
SAMN34331421	E177_07_1_1_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_1_1_1_R1.fq.gz
SAMN34331422	E177_07_1_1_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_1_1_1_R1.fq.gz
SAMN34331423	E177_07_1_1_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_1_1_1_R1.fq.gz
SAMN34331424	E177_07_1_1_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_1_1_1_R1.fq.gz
SAMN34331425	E177_07_1_1_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_1_1_1_R1.fq.gz
SAMN34331426	E177_07_1_1_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_1_1_1_R1.fq.gz
SAMN34331427	E177_07_1_1_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_1_1_1_R1.fq.gz
SAMN34331428	E177_07_1_1_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_1_1_1_R1.fq.gz
SAMN34331256	E177_07_1_1_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_1_1_1_R1.fq.gz
SAMN34331267	E177_07_1_1_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_1_1_1_R1.fq.gz
SAMN34331429	E177_07_1_1_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_1_1_1_R1.fq.gz
SAMN34331430	E177_07_1_1_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_1_1_1_R1.fq.gz
SAMN34331431	E177_07_1_1_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_1_1_1_R1.fq.gz
SAMN34331432	E177_07_1_1_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_1_1_1_R1.fq.gz
SAMN34331433	E177_07_1_1_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_1_1_1_R1.fq.gz
SAMN34331434	E177_07_1_1_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_1_1_1_R1.fq.gz
SAMN34331435	E177_07_1_1_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_1_1_1_R1.fq.gz
SAMN34331436	E177_07_1_1_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_1_1_1_R1.fq.gz
SAMN34331437	E177_07_1_1_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_1_1_1_R1.fq.gz
SAMN34331438	E177_07_1_1_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_1_1_1_R1.fq.gz
SAMN34331267	E177_07_1_1_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_1_1_1_R1.fq.gz
SAMN34331278	E177_07_1_1_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_1_1_1_R1.fq.gz
SAMN34331439	E177_07_1_1_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_1_1_1_R1.fq.gz
SAMN34331440	E177_07_1_1_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_1_1_1_R1.fq.gz
SAMN34331441	E177_07_1_1_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_1_1_1_R1.fq.gz
SAMN34331442	E177_07_1_1_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_1_1_1_R1.fq.gz
SAMN34331443	E177_07_1_1_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_1_1_1_R1.fq.gz
SAMN34331444	E177_07_1_1_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_1_1_1_R1.fq.gz
SAMN34331445	E177_07_1_1_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_1_1_1_R1.fq.gz
SAMN34331446	E177_07_1_1_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_1_1_1_R1.fq.gz
SAMN34331447	E177_07_1_1_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_1_1_1_R1.fq.gz
SAMN34331448	E177_07_1_1_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_1_1_1_R1.fq.gz
SAMN34331278	E177_07_1_1_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_1_1_1_R1.fq.gz
SAMN34331245	E177_07_1_1_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_1_1_1_R1.fq.gz
SAMN34331449	E177_07_1_1_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_1_1_1_R1.fq.gz
SAMN34331450	E177_07_1_1_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_1_1_1_R1.fq.gz
SAMN34331451	E177_07_1_1_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_1_1_1_R1.fq.gz
SAMN34331452	E177_07_1_1_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_1_1_1_R1.fq.gz
SAMN34331453	E177_07_1_1_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_1_1_1_R1.fq.gz
SAMN34331454	E177_07_1_1_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_1_1_1_R1.fq.gz
SAMN34331455	E177_07_1_1_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_1_1_1_R1.fq.gz
SAMN34331456	E177_07_1_1_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_1_1_1_R1.fq.gz
SAMN34331457	E177_07_1_1_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_1_1_1_R1.fq.gz
SAMN34331458	E177_07_1_1_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_1_1_1_R1.fq.gz
SAMN34331245	E177_07_1_1_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_1_1_1_R1.fq.gz
SAMN34331256	E177_07_1_1_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_1_1_1_R1.fq.gz
SAMN34331459	E177_07_1_1_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_1_1_1_R1.fq.gz
SAMN34331460	E177_07_1_1_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_1_1_1_R1.fq.gz
SAMN34331461	E177_07_1_1_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_1_1_1_R1.fq.gz
SAMN34331462	E177_07_1_1_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_1_1_1_R1.fq.gz
SAMN34331463	E177_07_1_1_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_1_1_1_R1.fq.gz
SAMN34331464	E177_07_1_1_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_1_1_1_R1.fq.gz
SAMN34331465	E177_07_1_1_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_1_1_1_R1.fq.gz
SAMN34331466	E177_07_1_1_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_1_1_1_R1.fq.gz
SAMN34331467	E177_07_1_1_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_1_1_1_R1.fq.gz
SAMN34331468	E177_07_1_1_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_1_1_1_R1.fq.gz
SAMN34331256	E177_07_1_1_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_1_1_1_R1.fq.gz
SAMN34331267	E177_07_1_1_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_1_1_1_R1.fq.gz
SAMN34331469	E177_07_1_1_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_1_1_1_R1.fq.gz
SAMN34331470	E177_07_1_1_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_1_1_1_R1.fq.gz
SAMN34331471	E177_07_1_1_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_1_1_1_R1.fq.gz
SAMN34331472	E177_07_1_1_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_1_1_1_R1.fq.gz
SAMN34331473	E177_07_1_1_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_1_1_1_R1.fq.gz
SAMN34331474	E177_07_1_1_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_1_1_1_R1.fq.gz
SAMN34331475	E177_07_1_1_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_1_1_1_R1.fq.gz
SAMN34331476	E177_07_1_1_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_1_1_1_R1.fq.gz
SAMN34331477	E177_07_1_1_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_1_1_1_R1.fq.gz
SAMN34331478	E177_07_1_1_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_1_1_1_R1.fq.gz
SAMN34331267	E177_07_1_1_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_1_1_1_R1.fq.gz
SAMN34331278	E177_07_1_1_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_1_1_1_R1.fq.gz
SAMN34331479	E177_07_1_1_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_1_1_1_R1.fq.gz
SAMN34331480	E177_07_1_1_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_1_1_1_R1.fq.gz
SAMN34331481	E177_07_1_1_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_1_1_1_R1.fq.gz
SAMN34331482	E177_07_1_1_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_1_1_1_R1.fq.gz
SAMN34331483	E177_07_1_1_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_1_1_1_R1.fq.gz
SAMN34331484	E177_07_1_1_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_1_1_1_R1.fq.gz
SAMN34331485	E177_07_1_1_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_1_1_1_R1.fq.gz
SAMN34331486	E177_07_1_1_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_1_1_1_R1.fq.gz
SAMN34331487	E177_07_1_1_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_1_1_1_R1.fq.gz
SAMN34331488	E177_07_1_1_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_1_1_1_R1.fq.gz
SAMN34331278	E177_07_1_1_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_1_1_1_R1.fq.gz
SAMN34331245	E177_08_1_1_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_1_1_2_R1.fq.gz
SAMN34331489	E177_08_1_1_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_1_1_2_R1.fq.gz
SAMN34331490	E177_08_1_1_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_1_1_2_R1.fq.gz
SAMN34331491	E177_08_1_1_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_1_1_2_R1.fq.gz
SAMN34331492	E177_08_1_1_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_1_1_2_R1.fq.gz
SAMN34331493	E177_08_1_1_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_1_1_2_R1.fq.gz
SAMN34331494	E177_08_1_1_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_1_1_2_R1.fq.gz
SAMN34331495	E177_08_1_1_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_1_1_2_R1.fq.gz
SAMN34331496	E177_08_1_1_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_1_1_2_R1.fq.gz
SAMN34331497	E177_08_1_1_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_1_1_2_R1.fq.gz
SAMN34331498	E177_08_1_1_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_1_1_2_R1.fq.gz
SAMN34331245	E177_08_1_1_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_1_1_2_R1.fq.gz
SAMN34331256	E177_08_1_1_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_1_1_2_R1.fq.gz
SAMN34331499	E177_08_1_1_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_1_1_2_R1.fq.gz
SAMN34331500	E177_08_1_1_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_1_1_2_R1.fq.gz
SAMN34331501	E177_08_1_1_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_1_1_2_R1.fq.gz
SAMN34331502	E177_08_1_1_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_1_1_2_R1.fq.gz
SAMN34331503	E177_08_1_1_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_1_1_2_R1.fq.gz
SAMN34331504	E177_08_1_1_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_1_1_2_R1.fq.gz
SAMN34331505	E177_08_1_1_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_1_1_2_R1.fq.gz
SAMN34331506	E177_08_1_1_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_1_1_2_R1.fq.gz
SAMN34331507	E177_08_1_1_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_1_1_2_R1.fq.gz
SAMN34331508	E177_08_1_1_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_1_1_2_R1.fq.gz
SAMN34331256	E177_08_1_1_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_1_1_2_R1.fq.gz
SAMN34331267	E177_08_1_1_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_1_1_2_R1.fq.gz
SAMN34331509	E177_08_1_1_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_1_1_2_R1.fq.gz
SAMN34331510	E177_08_1_1_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_1_1_2_R1.fq.gz
SAMN34331511	E177_08_1_1_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_1_1_2_R1.fq.gz
SAMN34331512	E177_08_1_1_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_1_1_2_R1.fq.gz
SAMN34331513	E177_08_1_1_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_1_1_2_R1.fq.gz
SAMN34331514	E177_08_1_1_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_1_1_2_R1.fq.gz
SAMN34331515	E177_08_1_1_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_1_1_2_R1.fq.gz
SAMN34331516	E177_08_1_1_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_1_1_2_R1.fq.gz
SAMN34331517	E177_08_1_1_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_1_1_2_R1.fq.gz
SAMN34331518	E177_08_1_1_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_1_1_2_R1.fq.gz
SAMN34331267	E177_08_1_1_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_1_1_2_R1.fq.gz
SAMN34331278	E177_08_1_1_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_1_1_2_R1.fq.gz
SAMN34331519	E177_08_1_1_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_1_1_2_R1.fq.gz
SAMN34331520	E177_08_1_1_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_1_1_2_R1.fq.gz
SAMN34331521	E177_08_1_1_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_1_1_2_R1.fq.gz
SAMN34331522	E177_08_1_1_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_1_1_2_R1.fq.gz
SAMN34331523	E177_08_1_1_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_1_1_2_R1.fq.gz
SAMN34331524	E177_08_1_1_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_1_1_2_R1.fq.gz
SAMN34331525	E177_08_1_1_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_1_1_2_R1.fq.gz
SAMN34331526	E177_08_1_1_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_1_1_2_R1.fq.gz
SAMN34331527	E177_08_1_1_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_1_1_2_R1.fq.gz
SAMN34331528	E177_08_1_1_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_1_1_2_R1.fq.gz
SAMN34331278	E177_08_1_1_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_1_1_2_R1.fq.gz
SAMN34331245	E177_08_1_1_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_1_1_2_R1.fq.gz
SAMN34331529	E177_08_1_1_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_1_1_2_R1.fq.gz
SAMN34331530	E177_08_1_1_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_1_1_2_R1.fq.gz
SAMN34331531	E177_08_1_1_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_1_1_2_R1.fq.gz
SAMN34331532	E177_08_1_1_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_1_1_2_R1.fq.gz
SAMN34331533	E177_08_1_1_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_1_1_2_R1.fq.gz
SAMN34331534	E177_08_1_1_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_1_1_2_R1.fq.gz
SAMN34331535	E177_08_1_1_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_1_1_2_R1.fq.gz
SAMN34331536	E177_08_1_1_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_1_1_2_R1.fq.gz
SAMN34331537	E177_08_1_1_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_1_1_2_R1.fq.gz
SAMN34331538	E177_08_1_1_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_1_1_2_R1.fq.gz
SAMN34331245	E177_08_1_1_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_1_1_2_R1.fq.gz
SAMN34331256	E177_08_1_1_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_1_1_2_R1.fq.gz
SAMN34331539	E177_08_1_1_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_1_1_2_R1.fq.gz
SAMN34331540	E177_08_1_1_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_1_1_2_R1.fq.gz
SAMN34331541	E177_08_1_1_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_1_1_2_R1.fq.gz
SAMN34331542	E177_08_1_1_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_1_1_2_R1.fq.gz
SAMN34331543	E177_08_1_1_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_1_1_2_R1.fq.gz
SAMN34331544	E177_08_1_1_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_1_1_2_R1.fq.gz
SAMN34331545	E177_08_1_1_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_1_1_2_R1.fq.gz
SAMN34331546	E177_08_1_1_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_1_1_2_R1.fq.gz
SAMN34331547	E177_08_1_1_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_1_1_2_R1.fq.gz
SAMN34331548	E177_08_1_1_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_1_1_2_R1.fq.gz
SAMN34331256	E177_08_1_1_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_1_1_2_R1.fq.gz
SAMN34331267	E177_08_1_1_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_1_1_2_R1.fq.gz
SAMN34331549	E177_08_1_1_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_1_1_2_R1.fq.gz
SAMN34331550	E177_08_1_1_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_1_1_2_R1.fq.gz
SAMN34331551	E177_08_1_1_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_1_1_2_R1.fq.gz
SAMN34331552	E177_08_1_1_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_1_1_2_R1.fq.gz
SAMN34331553	E177_08_1_1_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_1_1_2_R1.fq.gz
SAMN34331554	E177_08_1_1_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_1_1_2_R1.fq.gz
SAMN34331555	E177_08_1_1_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_1_1_2_R1.fq.gz
SAMN34331556	E177_08_1_1_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_1_1_2_R1.fq.gz
SAMN34331557	E177_08_1_1_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_1_1_2_R1.fq.gz
SAMN34331558	E177_08_1_1_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_1_1_2_R1.fq.gz
SAMN34331267	E177_08_1_1_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_1_1_2_R1.fq.gz
SAMN34331278	E177_08_1_1_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_1_1_2_R1.fq.gz
SAMN34331559	E177_08_1_1_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_1_1_2_R1.fq.gz
SAMN34331560	E177_08_1_1_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_1_1_2_R1.fq.gz
SAMN34331561	E177_08_1_1_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_1_1_2_R1.fq.gz
SAMN34331562	E177_08_1_1_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_1_1_2_R1.fq.gz
SAMN34331563	E177_08_1_1_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_1_1_2_R1.fq.gz
SAMN34331564	E177_08_1_1_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_1_1_2_R1.fq.gz
SAMN34331565	E177_08_1_1_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_1_1_2_R1.fq.gz
SAMN34331566	E177_08_1_1_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_1_1_2_R1.fq.gz
SAMN34331567	E177_08_1_1_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_1_1_2_R1.fq.gz
SAMN34331568	E177_08_1_1_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_1_1_2_R1.fq.gz
SAMN34331278	E177_08_1_1_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_1_1_2_R1.fq.gz
SAMN34331245	E177_09_1_2_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_1_2_1_R1.fq.gz
SAMN34331409	E177_09_1_2_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_1_2_1_R1.fq.gz
SAMN34331410	E177_09_1_2_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_1_2_1_R1.fq.gz
SAMN34331411	E177_09_1_2_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_1_2_1_R1.fq.gz
SAMN34331412	E177_09_1_2_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_1_2_1_R1.fq.gz
SAMN34331413	E177_09_1_2_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_1_2_1_R1.fq.gz
SAMN34331414	E177_09_1_2_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_1_2_1_R1.fq.gz
SAMN34331415	E177_09_1_2_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_1_2_1_R1.fq.gz
SAMN34331416	E177_09_1_2_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_1_2_1_R1.fq.gz
SAMN34331417	E177_09_1_2_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_1_2_1_R1.fq.gz
SAMN34331418	E177_09_1_2_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_1_2_1_R1.fq.gz
SAMN34331245	E177_09_1_2_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_1_2_1_R1.fq.gz
SAMN34331256	E177_09_1_2_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_1_2_1_R1.fq.gz
SAMN34331419	E177_09_1_2_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_1_2_1_R1.fq.gz
SAMN34331420	E177_09_1_2_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_1_2_1_R1.fq.gz
SAMN34331421	E177_09_1_2_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_1_2_1_R1.fq.gz
SAMN34331422	E177_09_1_2_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_1_2_1_R1.fq.gz
SAMN34331423	E177_09_1_2_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_1_2_1_R1.fq.gz
SAMN34331424	E177_09_1_2_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_1_2_1_R1.fq.gz
SAMN34331425	E177_09_1_2_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_1_2_1_R1.fq.gz
SAMN34331426	E177_09_1_2_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_1_2_1_R1.fq.gz
SAMN34331427	E177_09_1_2_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_1_2_1_R1.fq.gz
SAMN34331428	E177_09_1_2_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_1_2_1_R1.fq.gz
SAMN34331256	E177_09_1_2_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_1_2_1_R1.fq.gz
SAMN34331267	E177_09_1_2_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_1_2_1_R1.fq.gz
SAMN34331429	E177_09_1_2_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_1_2_1_R1.fq.gz
SAMN34331430	E177_09_1_2_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_1_2_1_R1.fq.gz
SAMN34331431	E177_09_1_2_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_1_2_1_R1.fq.gz
SAMN34331432	E177_09_1_2_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_1_2_1_R1.fq.gz
SAMN34331433	E177_09_1_2_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_1_2_1_R1.fq.gz
SAMN34331434	E177_09_1_2_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_1_2_1_R1.fq.gz
SAMN34331435	E177_09_1_2_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_1_2_1_R1.fq.gz
SAMN34331436	E177_09_1_2_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_1_2_1_R1.fq.gz
SAMN34331437	E177_09_1_2_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_1_2_1_R1.fq.gz
SAMN34331438	E177_09_1_2_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_1_2_1_R1.fq.gz
SAMN34331267	E177_09_1_2_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_1_2_1_R1.fq.gz
SAMN34331278	E177_09_1_2_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_1_2_1_R1.fq.gz
SAMN34331439	E177_09_1_2_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_1_2_1_R1.fq.gz
SAMN34331440	E177_09_1_2_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_1_2_1_R1.fq.gz
SAMN34331441	E177_09_1_2_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_1_2_1_R1.fq.gz
SAMN34331442	E177_09_1_2_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_1_2_1_R1.fq.gz
SAMN34331443	E177_09_1_2_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_1_2_1_R1.fq.gz
SAMN34331444	E177_09_1_2_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_1_2_1_R1.fq.gz
SAMN34331445	E177_09_1_2_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_1_2_1_R1.fq.gz
SAMN34331446	E177_09_1_2_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_1_2_1_R1.fq.gz
SAMN34331447	E177_09_1_2_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_1_2_1_R1.fq.gz
SAMN34331448	E177_09_1_2_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_1_2_1_R1.fq.gz
SAMN34331278	E177_09_1_2_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_1_2_1_R1.fq.gz
SAMN34331245	E177_09_1_2_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_1_2_1_R1.fq.gz
SAMN34331449	E177_09_1_2_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_1_2_1_R1.fq.gz
SAMN34331450	E177_09_1_2_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_1_2_1_R1.fq.gz
SAMN34331451	E177_09_1_2_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_1_2_1_R1.fq.gz
SAMN34331452	E177_09_1_2_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_1_2_1_R1.fq.gz
SAMN34331453	E177_09_1_2_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_1_2_1_R1.fq.gz
SAMN34331454	E177_09_1_2_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_1_2_1_R1.fq.gz
SAMN34331455	E177_09_1_2_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_1_2_1_R1.fq.gz
SAMN34331456	E177_09_1_2_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_1_2_1_R1.fq.gz
SAMN34331457	E177_09_1_2_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_1_2_1_R1.fq.gz
SAMN34331458	E177_09_1_2_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_1_2_1_R1.fq.gz
SAMN34331245	E177_09_1_2_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_1_2_1_R1.fq.gz
SAMN34331256	E177_09_1_2_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_1_2_1_R1.fq.gz
SAMN34331459	E177_09_1_2_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_1_2_1_R1.fq.gz
SAMN34331460	E177_09_1_2_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_1_2_1_R1.fq.gz
SAMN34331461	E177_09_1_2_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_1_2_1_R1.fq.gz
SAMN34331462	E177_09_1_2_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_1_2_1_R1.fq.gz
SAMN34331463	E177_09_1_2_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_1_2_1_R1.fq.gz
SAMN34331464	E177_09_1_2_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_1_2_1_R1.fq.gz
SAMN34331465	E177_09_1_2_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_1_2_1_R1.fq.gz
SAMN34331466	E177_09_1_2_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_1_2_1_R1.fq.gz
SAMN34331467	E177_09_1_2_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_1_2_1_R1.fq.gz
SAMN34331468	E177_09_1_2_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_1_2_1_R1.fq.gz
SAMN34331256	E177_09_1_2_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_1_2_1_R1.fq.gz
SAMN34331267	E177_09_1_2_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_1_2_1_R1.fq.gz
SAMN34331469	E177_09_1_2_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_1_2_1_R1.fq.gz
SAMN34331470	E177_09_1_2_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_1_2_1_R1.fq.gz
SAMN34331471	E177_09_1_2_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_1_2_1_R1.fq.gz
SAMN34331472	E177_09_1_2_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_1_2_1_R1.fq.gz
SAMN34331473	E177_09_1_2_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_1_2_1_R1.fq.gz
SAMN34331474	E177_09_1_2_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_1_2_1_R1.fq.gz
SAMN34331475	E177_09_1_2_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_1_2_1_R1.fq.gz
SAMN34331476	E177_09_1_2_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_1_2_1_R1.fq.gz
SAMN34331477	E177_09_1_2_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_1_2_1_R1.fq.gz
SAMN34331478	E177_09_1_2_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_1_2_1_R1.fq.gz
SAMN34331267	E177_09_1_2_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_1_2_1_R1.fq.gz
SAMN34331278	E177_09_1_2_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_1_2_1_R1.fq.gz
SAMN34331479	E177_09_1_2_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_1_2_1_R1.fq.gz
SAMN34331480	E177_09_1_2_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_1_2_1_R1.fq.gz
SAMN34331481	E177_09_1_2_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_1_2_1_R1.fq.gz
SAMN34331482	E177_09_1_2_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_1_2_1_R1.fq.gz
SAMN34331483	E177_09_1_2_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_1_2_1_R1.fq.gz
SAMN34331484	E177_09_1_2_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_1_2_1_R1.fq.gz
SAMN34331485	E177_09_1_2_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_1_2_1_R1.fq.gz
SAMN34331486	E177_09_1_2_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_1_2_1_R1.fq.gz
SAMN34331487	E177_09_1_2_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_1_2_1_R1.fq.gz
SAMN34331488	E177_09_1_2_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_1_2_1_R1.fq.gz
SAMN34331278	E177_09_1_2_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_1_2_1_R1.fq.gz
SAMN34331245	E177_10_1_2_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_1_2_2_R1.fq.gz
SAMN34331489	E177_10_1_2_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_1_2_2_R1.fq.gz
SAMN34331490	E177_10_1_2_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_1_2_2_R1.fq.gz
SAMN34331491	E177_10_1_2_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_1_2_2_R1.fq.gz
SAMN34331492	E177_10_1_2_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_1_2_2_R1.fq.gz
SAMN34331493	E177_10_1_2_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_1_2_2_R1.fq.gz
SAMN34331494	E177_10_1_2_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_1_2_2_R1.fq.gz
SAMN34331495	E177_10_1_2_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_1_2_2_R1.fq.gz
SAMN34331496	E177_10_1_2_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_1_2_2_R1.fq.gz
SAMN34331497	E177_10_1_2_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_1_2_2_R1.fq.gz
SAMN34331498	E177_10_1_2_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_1_2_2_R1.fq.gz
SAMN34331245	E177_10_1_2_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_1_2_2_R1.fq.gz
SAMN34331256	E177_10_1_2_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_1_2_2_R1.fq.gz
SAMN34331499	E177_10_1_2_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_1_2_2_R1.fq.gz
SAMN34331500	E177_10_1_2_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_1_2_2_R1.fq.gz
SAMN34331501	E177_10_1_2_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_1_2_2_R1.fq.gz
SAMN34331502	E177_10_1_2_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_1_2_2_R1.fq.gz
SAMN34331503	E177_10_1_2_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_1_2_2_R1.fq.gz
SAMN34331504	E177_10_1_2_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_1_2_2_R1.fq.gz
SAMN34331505	E177_10_1_2_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_1_2_2_R1.fq.gz
SAMN34331506	E177_10_1_2_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_1_2_2_R1.fq.gz
SAMN34331507	E177_10_1_2_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_1_2_2_R1.fq.gz
SAMN34331508	E177_10_1_2_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_1_2_2_R1.fq.gz
SAMN34331256	E177_10_1_2_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_1_2_2_R1.fq.gz
SAMN34331267	E177_10_1_2_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_1_2_2_R1.fq.gz
SAMN34331509	E177_10_1_2_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_1_2_2_R1.fq.gz
SAMN34331510	E177_10_1_2_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_1_2_2_R1.fq.gz
SAMN34331511	E177_10_1_2_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_1_2_2_R1.fq.gz
SAMN34331512	E177_10_1_2_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_1_2_2_R1.fq.gz
SAMN34331513	E177_10_1_2_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_1_2_2_R1.fq.gz
SAMN34331514	E177_10_1_2_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_1_2_2_R1.fq.gz
SAMN34331515	E177_10_1_2_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_1_2_2_R1.fq.gz
SAMN34331516	E177_10_1_2_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_1_2_2_R1.fq.gz
SAMN34331517	E177_10_1_2_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_1_2_2_R1.fq.gz
SAMN34331518	E177_10_1_2_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_1_2_2_R1.fq.gz
SAMN34331267	E177_10_1_2_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_1_2_2_R1.fq.gz
SAMN34331278	E177_10_1_2_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_1_2_2_R1.fq.gz
SAMN34331519	E177_10_1_2_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_1_2_2_R1.fq.gz
SAMN34331520	E177_10_1_2_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_1_2_2_R1.fq.gz
SAMN34331521	E177_10_1_2_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_1_2_2_R1.fq.gz
SAMN34331522	E177_10_1_2_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_1_2_2_R1.fq.gz
SAMN34331523	E177_10_1_2_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_1_2_2_R1.fq.gz
SAMN34331524	E177_10_1_2_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_1_2_2_R1.fq.gz
SAMN34331525	E177_10_1_2_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_1_2_2_R1.fq.gz
SAMN34331526	E177_10_1_2_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_1_2_2_R1.fq.gz
SAMN34331527	E177_10_1_2_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_1_2_2_R1.fq.gz
SAMN34331528	E177_10_1_2_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_1_2_2_R1.fq.gz
SAMN34331278	E177_10_1_2_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_1_2_2_R1.fq.gz
SAMN34331245	E177_10_1_2_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_1_2_2_R1.fq.gz
SAMN34331529	E177_10_1_2_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_1_2_2_R1.fq.gz
SAMN34331530	E177_10_1_2_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_1_2_2_R1.fq.gz
SAMN34331531	E177_10_1_2_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_1_2_2_R1.fq.gz
SAMN34331532	E177_10_1_2_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_1_2_2_R1.fq.gz
SAMN34331533	E177_10_1_2_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_1_2_2_R1.fq.gz
SAMN34331534	E177_10_1_2_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_1_2_2_R1.fq.gz
SAMN34331535	E177_10_1_2_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_1_2_2_R1.fq.gz
SAMN34331536	E177_10_1_2_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_1_2_2_R1.fq.gz
SAMN34331537	E177_10_1_2_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_1_2_2_R1.fq.gz
SAMN34331538	E177_10_1_2_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_1_2_2_R1.fq.gz
SAMN34331245	E177_10_1_2_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_1_2_2_R1.fq.gz
SAMN34331256	E177_10_1_2_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_1_2_2_R1.fq.gz
SAMN34331539	E177_10_1_2_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_1_2_2_R1.fq.gz
SAMN34331540	E177_10_1_2_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_1_2_2_R1.fq.gz
SAMN34331541	E177_10_1_2_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_1_2_2_R1.fq.gz
SAMN34331542	E177_10_1_2_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_1_2_2_R1.fq.gz
SAMN34331543	E177_10_1_2_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_1_2_2_R1.fq.gz
SAMN34331544	E177_10_1_2_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_1_2_2_R1.fq.gz
SAMN34331545	E177_10_1_2_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_1_2_2_R1.fq.gz
SAMN34331546	E177_10_1_2_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_1_2_2_R1.fq.gz
SAMN34331547	E177_10_1_2_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_1_2_2_R1.fq.gz
SAMN34331548	E177_10_1_2_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_1_2_2_R1.fq.gz
SAMN34331256	E177_10_1_2_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_1_2_2_R1.fq.gz
SAMN34331267	E177_10_1_2_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_1_2_2_R1.fq.gz
SAMN34331549	E177_10_1_2_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_1_2_2_R1.fq.gz
SAMN34331550	E177_10_1_2_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_1_2_2_R1.fq.gz
SAMN34331551	E177_10_1_2_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_1_2_2_R1.fq.gz
SAMN34331552	E177_10_1_2_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_1_2_2_R1.fq.gz
SAMN34331553	E177_10_1_2_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_1_2_2_R1.fq.gz
SAMN34331554	E177_10_1_2_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_1_2_2_R1.fq.gz
SAMN34331555	E177_10_1_2_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_1_2_2_R1.fq.gz
SAMN34331556	E177_10_1_2_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_1_2_2_R1.fq.gz
SAMN34331557	E177_10_1_2_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_1_2_2_R1.fq.gz
SAMN34331558	E177_10_1_2_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_1_2_2_R1.fq.gz
SAMN34331267	E177_10_1_2_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_1_2_2_R1.fq.gz
SAMN34331278	E177_10_1_2_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_1_2_2_R1.fq.gz
SAMN34331559	E177_10_1_2_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_1_2_2_R1.fq.gz
SAMN34331560	E177_10_1_2_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_1_2_2_R1.fq.gz
SAMN34331561	E177_10_1_2_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_1_2_2_R1.fq.gz
SAMN34331562	E177_10_1_2_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_1_2_2_R1.fq.gz
SAMN34331563	E177_10_1_2_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_1_2_2_R1.fq.gz
SAMN34331564	E177_10_1_2_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_1_2_2_R1.fq.gz
SAMN34331565	E177_10_1_2_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_1_2_2_R1.fq.gz
SAMN34331566	E177_10_1_2_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_1_2_2_R1.fq.gz
SAMN34331567	E177_10_1_2_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_1_2_2_R1.fq.gz
SAMN34331568	E177_10_1_2_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_1_2_2_R1.fq.gz
SAMN34331278	E177_10_1_2_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_1_2_2_R1.fq.gz
SAMN34331245	E177_11_1_3_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_1_3_1_R1.fq.gz
SAMN34331409	E177_11_1_3_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_1_3_1_R1.fq.gz
SAMN34331410	E177_11_1_3_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_1_3_1_R1.fq.gz
SAMN34331411	E177_11_1_3_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_1_3_1_R1.fq.gz
SAMN34331412	E177_11_1_3_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_1_3_1_R1.fq.gz
SAMN34331413	E177_11_1_3_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_1_3_1_R1.fq.gz
SAMN34331414	E177_11_1_3_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_1_3_1_R1.fq.gz
SAMN34331415	E177_11_1_3_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_1_3_1_R1.fq.gz
SAMN34331416	E177_11_1_3_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_1_3_1_R1.fq.gz
SAMN34331417	E177_11_1_3_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_1_3_1_R1.fq.gz
SAMN34331418	E177_11_1_3_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_1_3_1_R1.fq.gz
SAMN34331245	E177_11_1_3_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_1_3_1_R1.fq.gz
SAMN34331256	E177_11_1_3_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_1_3_1_R1.fq.gz
SAMN34331419	E177_11_1_3_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_1_3_1_R1.fq.gz
SAMN34331420	E177_11_1_3_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_1_3_1_R1.fq.gz
SAMN34331421	E177_11_1_3_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_1_3_1_R1.fq.gz
SAMN34331422	E177_11_1_3_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_1_3_1_R1.fq.gz
SAMN34331423	E177_11_1_3_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_1_3_1_R1.fq.gz
SAMN34331424	E177_11_1_3_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_1_3_1_R1.fq.gz
SAMN34331425	E177_11_1_3_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_1_3_1_R1.fq.gz
SAMN34331426	E177_11_1_3_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_1_3_1_R1.fq.gz
SAMN34331427	E177_11_1_3_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_1_3_1_R1.fq.gz
SAMN34331428	E177_11_1_3_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_1_3_1_R1.fq.gz
SAMN34331256	E177_11_1_3_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_1_3_1_R1.fq.gz
SAMN34331267	E177_11_1_3_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_1_3_1_R1.fq.gz
SAMN34331429	E177_11_1_3_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_1_3_1_R1.fq.gz
SAMN34331430	E177_11_1_3_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_1_3_1_R1.fq.gz
SAMN34331431	E177_11_1_3_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_1_3_1_R1.fq.gz
SAMN34331432	E177_11_1_3_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_1_3_1_R1.fq.gz
SAMN34331433	E177_11_1_3_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_1_3_1_R1.fq.gz
SAMN34331434	E177_11_1_3_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_1_3_1_R1.fq.gz
SAMN34331435	E177_11_1_3_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_1_3_1_R1.fq.gz
SAMN34331436	E177_11_1_3_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_1_3_1_R1.fq.gz
SAMN34331437	E177_11_1_3_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_1_3_1_R1.fq.gz
SAMN34331438	E177_11_1_3_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_1_3_1_R1.fq.gz
SAMN34331267	E177_11_1_3_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_1_3_1_R1.fq.gz
SAMN34331278	E177_11_1_3_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_1_3_1_R1.fq.gz
SAMN34331439	E177_11_1_3_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_1_3_1_R1.fq.gz
SAMN34331440	E177_11_1_3_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_1_3_1_R1.fq.gz
SAMN34331441	E177_11_1_3_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_1_3_1_R1.fq.gz
SAMN34331442	E177_11_1_3_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_1_3_1_R1.fq.gz
SAMN34331443	E177_11_1_3_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_1_3_1_R1.fq.gz
SAMN34331444	E177_11_1_3_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_1_3_1_R1.fq.gz
SAMN34331445	E177_11_1_3_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_1_3_1_R1.fq.gz
SAMN34331446	E177_11_1_3_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_1_3_1_R1.fq.gz
SAMN34331447	E177_11_1_3_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_1_3_1_R1.fq.gz
SAMN34331448	E177_11_1_3_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_1_3_1_R1.fq.gz
SAMN34331278	E177_11_1_3_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_1_3_1_R1.fq.gz
SAMN34331245	E177_11_1_3_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_1_3_1_R1.fq.gz
SAMN34331449	E177_11_1_3_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_1_3_1_R1.fq.gz
SAMN34331450	E177_11_1_3_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_1_3_1_R1.fq.gz
SAMN34331451	E177_11_1_3_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_1_3_1_R1.fq.gz
SAMN34331452	E177_11_1_3_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_1_3_1_R1.fq.gz
SAMN34331453	E177_11_1_3_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_1_3_1_R1.fq.gz
SAMN34331454	E177_11_1_3_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_1_3_1_R1.fq.gz
SAMN34331455	E177_11_1_3_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_1_3_1_R1.fq.gz
SAMN34331456	E177_11_1_3_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_1_3_1_R1.fq.gz
SAMN34331457	E177_11_1_3_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_1_3_1_R1.fq.gz
SAMN34331458	E177_11_1_3_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_1_3_1_R1.fq.gz
SAMN34331245	E177_11_1_3_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_1_3_1_R1.fq.gz
SAMN34331256	E177_11_1_3_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_1_3_1_R1.fq.gz
SAMN34331459	E177_11_1_3_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_1_3_1_R1.fq.gz
SAMN34331460	E177_11_1_3_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_1_3_1_R1.fq.gz
SAMN34331461	E177_11_1_3_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_1_3_1_R1.fq.gz
SAMN34331462	E177_11_1_3_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_1_3_1_R1.fq.gz
SAMN34331463	E177_11_1_3_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_1_3_1_R1.fq.gz
SAMN34331464	E177_11_1_3_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_1_3_1_R1.fq.gz
SAMN34331465	E177_11_1_3_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_1_3_1_R1.fq.gz
SAMN34331466	E177_11_1_3_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_1_3_1_R1.fq.gz
SAMN34331467	E177_11_1_3_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_1_3_1_R1.fq.gz
SAMN34331468	E177_11_1_3_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_1_3_1_R1.fq.gz
SAMN34331256	E177_11_1_3_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_1_3_1_R1.fq.gz
SAMN34331267	E177_11_1_3_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_1_3_1_R1.fq.gz
SAMN34331469	E177_11_1_3_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_1_3_1_R1.fq.gz
SAMN34331470	E177_11_1_3_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_1_3_1_R1.fq.gz
SAMN34331471	E177_11_1_3_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_1_3_1_R1.fq.gz
SAMN34331472	E177_11_1_3_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_1_3_1_R1.fq.gz
SAMN34331473	E177_11_1_3_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_1_3_1_R1.fq.gz
SAMN34331474	E177_11_1_3_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_1_3_1_R1.fq.gz
SAMN34331475	E177_11_1_3_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_1_3_1_R1.fq.gz
SAMN34331476	E177_11_1_3_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_1_3_1_R1.fq.gz
SAMN34331477	E177_11_1_3_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_1_3_1_R1.fq.gz
SAMN34331478	E177_11_1_3_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_1_3_1_R1.fq.gz
SAMN34331267	E177_11_1_3_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_1_3_1_R1.fq.gz
SAMN34331278	E177_11_1_3_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_1_3_1_R1.fq.gz
SAMN34331479	E177_11_1_3_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_1_3_1_R1.fq.gz
SAMN34331480	E177_11_1_3_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_1_3_1_R1.fq.gz
SAMN34331481	E177_11_1_3_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_1_3_1_R1.fq.gz
SAMN34331482	E177_11_1_3_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_1_3_1_R1.fq.gz
SAMN34331483	E177_11_1_3_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_1_3_1_R1.fq.gz
SAMN34331484	E177_11_1_3_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_1_3_1_R1.fq.gz
SAMN34331485	E177_11_1_3_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_1_3_1_R1.fq.gz
SAMN34331486	E177_11_1_3_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_1_3_1_R1.fq.gz
SAMN34331487	E177_11_1_3_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_1_3_1_R1.fq.gz
SAMN34331488	E177_11_1_3_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_1_3_1_R1.fq.gz
SAMN34331278	E177_11_1_3_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_1_3_1_R1.fq.gz
SAMN34331245	E177_12_1_3_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_1_3_2_R1.fq.gz
SAMN34331489	E177_12_1_3_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_1_3_2_R1.fq.gz
SAMN34331490	E177_12_1_3_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_1_3_2_R1.fq.gz
SAMN34331491	E177_12_1_3_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_1_3_2_R1.fq.gz
SAMN34331492	E177_12_1_3_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_1_3_2_R1.fq.gz
SAMN34331493	E177_12_1_3_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_1_3_2_R1.fq.gz
SAMN34331494	E177_12_1_3_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_1_3_2_R1.fq.gz
SAMN34331495	E177_12_1_3_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_1_3_2_R1.fq.gz
SAMN34331496	E177_12_1_3_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_1_3_2_R1.fq.gz
SAMN34331497	E177_12_1_3_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_1_3_2_R1.fq.gz
SAMN34331498	E177_12_1_3_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_1_3_2_R1.fq.gz
SAMN34331245	E177_12_1_3_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_1_3_2_R1.fq.gz
SAMN34331256	E177_12_1_3_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_1_3_2_R1.fq.gz
SAMN34331499	E177_12_1_3_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_1_3_2_R1.fq.gz
SAMN34331500	E177_12_1_3_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_1_3_2_R1.fq.gz
SAMN34331501	E177_12_1_3_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_1_3_2_R1.fq.gz
SAMN34331502	E177_12_1_3_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_1_3_2_R1.fq.gz
SAMN34331503	E177_12_1_3_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_1_3_2_R1.fq.gz
SAMN34331504	E177_12_1_3_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_1_3_2_R1.fq.gz
SAMN34331505	E177_12_1_3_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_1_3_2_R1.fq.gz
SAMN34331506	E177_12_1_3_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_1_3_2_R1.fq.gz
SAMN34331507	E177_12_1_3_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_1_3_2_R1.fq.gz
SAMN34331508	E177_12_1_3_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_1_3_2_R1.fq.gz
SAMN34331256	E177_12_1_3_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_1_3_2_R1.fq.gz
SAMN34331267	E177_12_1_3_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_1_3_2_R1.fq.gz
SAMN34331509	E177_12_1_3_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_1_3_2_R1.fq.gz
SAMN34331510	E177_12_1_3_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_1_3_2_R1.fq.gz
SAMN34331511	E177_12_1_3_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_1_3_2_R1.fq.gz
SAMN34331512	E177_12_1_3_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_1_3_2_R1.fq.gz
SAMN34331513	E177_12_1_3_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_1_3_2_R1.fq.gz
SAMN34331514	E177_12_1_3_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_1_3_2_R1.fq.gz
SAMN34331515	E177_12_1_3_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_1_3_2_R1.fq.gz
SAMN34331516	E177_12_1_3_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_1_3_2_R1.fq.gz
SAMN34331517	E177_12_1_3_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_1_3_2_R1.fq.gz
SAMN34331518	E177_12_1_3_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_1_3_2_R1.fq.gz
SAMN34331267	E177_12_1_3_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_1_3_2_R1.fq.gz
SAMN34331278	E177_12_1_3_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_1_3_2_R1.fq.gz
SAMN34331519	E177_12_1_3_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_1_3_2_R1.fq.gz
SAMN34331520	E177_12_1_3_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_1_3_2_R1.fq.gz
SAMN34331521	E177_12_1_3_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_1_3_2_R1.fq.gz
SAMN34331522	E177_12_1_3_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_1_3_2_R1.fq.gz
SAMN34331523	E177_12_1_3_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_1_3_2_R1.fq.gz
SAMN34331524	E177_12_1_3_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_1_3_2_R1.fq.gz
SAMN34331525	E177_12_1_3_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_1_3_2_R1.fq.gz
SAMN34331526	E177_12_1_3_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_1_3_2_R1.fq.gz
SAMN34331527	E177_12_1_3_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_1_3_2_R1.fq.gz
SAMN34331528	E177_12_1_3_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_1_3_2_R1.fq.gz
SAMN34331278	E177_12_1_3_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_1_3_2_R1.fq.gz
SAMN34331245	E177_12_1_3_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_1_3_2_R1.fq.gz
SAMN34331529	E177_12_1_3_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_1_3_2_R1.fq.gz
SAMN34331530	E177_12_1_3_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_1_3_2_R1.fq.gz
SAMN34331531	E177_12_1_3_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_1_3_2_R1.fq.gz
SAMN34331532	E177_12_1_3_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_1_3_2_R1.fq.gz
SAMN34331533	E177_12_1_3_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_1_3_2_R1.fq.gz
SAMN34331534	E177_12_1_3_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_1_3_2_R1.fq.gz
SAMN34331535	E177_12_1_3_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_1_3_2_R1.fq.gz
SAMN34331536	E177_12_1_3_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_1_3_2_R1.fq.gz
SAMN34331537	E177_12_1_3_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_1_3_2_R1.fq.gz
SAMN34331538	E177_12_1_3_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_1_3_2_R1.fq.gz
SAMN34331245	E177_12_1_3_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_1_3_2_R1.fq.gz
SAMN34331256	E177_12_1_3_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_1_3_2_R1.fq.gz
SAMN34331539	E177_12_1_3_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_1_3_2_R1.fq.gz
SAMN34331540	E177_12_1_3_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_1_3_2_R1.fq.gz
SAMN34331541	E177_12_1_3_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_1_3_2_R1.fq.gz
SAMN34331542	E177_12_1_3_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_1_3_2_R1.fq.gz
SAMN34331543	E177_12_1_3_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_1_3_2_R1.fq.gz
SAMN34331544	E177_12_1_3_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_1_3_2_R1.fq.gz
SAMN34331545	E177_12_1_3_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_1_3_2_R1.fq.gz
SAMN34331546	E177_12_1_3_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_1_3_2_R1.fq.gz
SAMN34331547	E177_12_1_3_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_1_3_2_R1.fq.gz
SAMN34331548	E177_12_1_3_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_1_3_2_R1.fq.gz
SAMN34331256	E177_12_1_3_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_1_3_2_R1.fq.gz
SAMN34331267	E177_12_1_3_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_1_3_2_R1.fq.gz
SAMN34331549	E177_12_1_3_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_1_3_2_R1.fq.gz
SAMN34331550	E177_12_1_3_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_1_3_2_R1.fq.gz
SAMN34331551	E177_12_1_3_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_1_3_2_R1.fq.gz
SAMN34331552	E177_12_1_3_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_1_3_2_R1.fq.gz
SAMN34331553	E177_12_1_3_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_1_3_2_R1.fq.gz
SAMN34331554	E177_12_1_3_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_1_3_2_R1.fq.gz
SAMN34331555	E177_12_1_3_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_1_3_2_R1.fq.gz
SAMN34331556	E177_12_1_3_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_1_3_2_R1.fq.gz
SAMN34331557	E177_12_1_3_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_1_3_2_R1.fq.gz
SAMN34331558	E177_12_1_3_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_1_3_2_R1.fq.gz
SAMN34331267	E177_12_1_3_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_1_3_2_R1.fq.gz
SAMN34331278	E177_12_1_3_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_1_3_2_R1.fq.gz
SAMN34331559	E177_12_1_3_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_1_3_2_R1.fq.gz
SAMN34331560	E177_12_1_3_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_1_3_2_R1.fq.gz
SAMN34331561	E177_12_1_3_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_1_3_2_R1.fq.gz
SAMN34331562	E177_12_1_3_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_1_3_2_R1.fq.gz
SAMN34331563	E177_12_1_3_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_1_3_2_R1.fq.gz
SAMN34331564	E177_12_1_3_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_1_3_2_R1.fq.gz
SAMN34331565	E177_12_1_3_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_1_3_2_R1.fq.gz
SAMN34331566	E177_12_1_3_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_1_3_2_R1.fq.gz
SAMN34331567	E177_12_1_3_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_1_3_2_R1.fq.gz
SAMN34331568	E177_12_1_3_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_1_3_2_R1.fq.gz
SAMN34331278	E177_12_1_3_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_1_3_2_R1.fq.gz
SAMN34331245	E177_13_10_1_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_10_1_1_R1.fq.gz
SAMN34331569	E177_13_10_1_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_10_1_1_R1.fq.gz
SAMN34331570	E177_13_10_1_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_10_1_1_R1.fq.gz
SAMN34331571	E177_13_10_1_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_10_1_1_R1.fq.gz
SAMN34331572	E177_13_10_1_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_10_1_1_R1.fq.gz
SAMN34331573	E177_13_10_1_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_10_1_1_R1.fq.gz
SAMN34331574	E177_13_10_1_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_10_1_1_R1.fq.gz
SAMN34331575	E177_13_10_1_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_10_1_1_R1.fq.gz
SAMN34331576	E177_13_10_1_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_10_1_1_R1.fq.gz
SAMN34331577	E177_13_10_1_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_10_1_1_R1.fq.gz
SAMN34331578	E177_13_10_1_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_10_1_1_R1.fq.gz
SAMN34331245	E177_13_10_1_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_10_1_1_R1.fq.gz
SAMN34331256	E177_13_10_1_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_10_1_1_R1.fq.gz
SAMN34331579	E177_13_10_1_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_10_1_1_R1.fq.gz
SAMN34331580	E177_13_10_1_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_10_1_1_R1.fq.gz
SAMN34331581	E177_13_10_1_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_10_1_1_R1.fq.gz
SAMN34331582	E177_13_10_1_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_10_1_1_R1.fq.gz
SAMN34331583	E177_13_10_1_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_10_1_1_R1.fq.gz
SAMN34331584	E177_13_10_1_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_10_1_1_R1.fq.gz
SAMN34331585	E177_13_10_1_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_10_1_1_R1.fq.gz
SAMN34331586	E177_13_10_1_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_10_1_1_R1.fq.gz
SAMN34331587	E177_13_10_1_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_10_1_1_R1.fq.gz
SAMN34331588	E177_13_10_1_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_10_1_1_R1.fq.gz
SAMN34331256	E177_13_10_1_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_10_1_1_R1.fq.gz
SAMN34331267	E177_13_10_1_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_10_1_1_R1.fq.gz
SAMN34331589	E177_13_10_1_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_10_1_1_R1.fq.gz
SAMN34331590	E177_13_10_1_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_10_1_1_R1.fq.gz
SAMN34331591	E177_13_10_1_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_10_1_1_R1.fq.gz
SAMN34331592	E177_13_10_1_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_10_1_1_R1.fq.gz
SAMN34331593	E177_13_10_1_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_10_1_1_R1.fq.gz
SAMN34331594	E177_13_10_1_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_10_1_1_R1.fq.gz
SAMN34331595	E177_13_10_1_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_10_1_1_R1.fq.gz
SAMN34331596	E177_13_10_1_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_10_1_1_R1.fq.gz
SAMN34331597	E177_13_10_1_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_10_1_1_R1.fq.gz
SAMN34331598	E177_13_10_1_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_10_1_1_R1.fq.gz
SAMN34331267	E177_13_10_1_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_10_1_1_R1.fq.gz
SAMN34331278	E177_13_10_1_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_10_1_1_R1.fq.gz
SAMN34331599	E177_13_10_1_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_10_1_1_R1.fq.gz
SAMN34331600	E177_13_10_1_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_10_1_1_R1.fq.gz
SAMN34331601	E177_13_10_1_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_10_1_1_R1.fq.gz
SAMN34331602	E177_13_10_1_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_10_1_1_R1.fq.gz
SAMN34331603	E177_13_10_1_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_10_1_1_R1.fq.gz
SAMN34331604	E177_13_10_1_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_10_1_1_R1.fq.gz
SAMN34331605	E177_13_10_1_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_10_1_1_R1.fq.gz
SAMN34331606	E177_13_10_1_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_10_1_1_R1.fq.gz
SAMN34331607	E177_13_10_1_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_10_1_1_R1.fq.gz
SAMN34331608	E177_13_10_1_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_10_1_1_R1.fq.gz
SAMN34331278	E177_13_10_1_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_10_1_1_R1.fq.gz
SAMN34331245	E177_13_10_1_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_10_1_1_R1.fq.gz
SAMN34331609	E177_13_10_1_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_10_1_1_R1.fq.gz
SAMN34331610	E177_13_10_1_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_10_1_1_R1.fq.gz
SAMN34331611	E177_13_10_1_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_10_1_1_R1.fq.gz
SAMN34331612	E177_13_10_1_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_10_1_1_R1.fq.gz
SAMN34331613	E177_13_10_1_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_10_1_1_R1.fq.gz
SAMN34331614	E177_13_10_1_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_10_1_1_R1.fq.gz
SAMN34331615	E177_13_10_1_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_10_1_1_R1.fq.gz
SAMN34331616	E177_13_10_1_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_10_1_1_R1.fq.gz
SAMN34331617	E177_13_10_1_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_10_1_1_R1.fq.gz
SAMN34331618	E177_13_10_1_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_10_1_1_R1.fq.gz
SAMN34331245	E177_13_10_1_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_10_1_1_R1.fq.gz
SAMN34331256	E177_13_10_1_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_10_1_1_R1.fq.gz
SAMN34331619	E177_13_10_1_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_10_1_1_R1.fq.gz
SAMN34331620	E177_13_10_1_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_10_1_1_R1.fq.gz
SAMN34331621	E177_13_10_1_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_10_1_1_R1.fq.gz
SAMN34331622	E177_13_10_1_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_10_1_1_R1.fq.gz
SAMN34331623	E177_13_10_1_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_10_1_1_R1.fq.gz
SAMN34331624	E177_13_10_1_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_10_1_1_R1.fq.gz
SAMN34331625	E177_13_10_1_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_10_1_1_R1.fq.gz
SAMN34331626	E177_13_10_1_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_10_1_1_R1.fq.gz
SAMN34331627	E177_13_10_1_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_10_1_1_R1.fq.gz
SAMN34331628	E177_13_10_1_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_10_1_1_R1.fq.gz
SAMN34331256	E177_13_10_1_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_10_1_1_R1.fq.gz
SAMN34331267	E177_13_10_1_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_10_1_1_R1.fq.gz
SAMN34331629	E177_13_10_1_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_10_1_1_R1.fq.gz
SAMN34331630	E177_13_10_1_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_10_1_1_R1.fq.gz
SAMN34331631	E177_13_10_1_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_10_1_1_R1.fq.gz
SAMN34331632	E177_13_10_1_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_10_1_1_R1.fq.gz
SAMN34331633	E177_13_10_1_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_10_1_1_R1.fq.gz
SAMN34331634	E177_13_10_1_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_10_1_1_R1.fq.gz
SAMN34331635	E177_13_10_1_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_10_1_1_R1.fq.gz
SAMN34331636	E177_13_10_1_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_10_1_1_R1.fq.gz
SAMN34331637	E177_13_10_1_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_10_1_1_R1.fq.gz
SAMN34331638	E177_13_10_1_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_10_1_1_R1.fq.gz
SAMN34331267	E177_13_10_1_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_10_1_1_R1.fq.gz
SAMN34331278	E177_13_10_1_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_10_1_1_R1.fq.gz
SAMN34331639	E177_13_10_1_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_10_1_1_R1.fq.gz
SAMN34331640	E177_13_10_1_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_10_1_1_R1.fq.gz
SAMN34331641	E177_13_10_1_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_10_1_1_R1.fq.gz
SAMN34331642	E177_13_10_1_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_10_1_1_R1.fq.gz
SAMN34331643	E177_13_10_1_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_10_1_1_R1.fq.gz
SAMN34331644	E177_13_10_1_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_10_1_1_R1.fq.gz
SAMN34331645	E177_13_10_1_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_10_1_1_R1.fq.gz
SAMN34331646	E177_13_10_1_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_10_1_1_R1.fq.gz
SAMN34331647	E177_13_10_1_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_10_1_1_R1.fq.gz
SAMN34331648	E177_13_10_1_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_10_1_1_R1.fq.gz
SAMN34331278	E177_13_10_1_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_10_1_1_R1.fq.gz
SAMN34331245	E177_14_10_1_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_10_1_2_R1.fq.gz
SAMN34331649	E177_14_10_1_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_10_1_2_R1.fq.gz
SAMN34331650	E177_14_10_1_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_10_1_2_R1.fq.gz
SAMN34331651	E177_14_10_1_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_10_1_2_R1.fq.gz
SAMN34331652	E177_14_10_1_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_10_1_2_R1.fq.gz
SAMN34331653	E177_14_10_1_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_10_1_2_R1.fq.gz
SAMN34331654	E177_14_10_1_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_10_1_2_R1.fq.gz
SAMN34331655	E177_14_10_1_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_10_1_2_R1.fq.gz
SAMN34331656	E177_14_10_1_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_10_1_2_R1.fq.gz
SAMN34331657	E177_14_10_1_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_10_1_2_R1.fq.gz
SAMN34331658	E177_14_10_1_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_10_1_2_R1.fq.gz
SAMN34331245	E177_14_10_1_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_10_1_2_R1.fq.gz
SAMN34331256	E177_14_10_1_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_10_1_2_R1.fq.gz
SAMN34331659	E177_14_10_1_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_10_1_2_R1.fq.gz
SAMN34331660	E177_14_10_1_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_10_1_2_R1.fq.gz
SAMN34331661	E177_14_10_1_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_10_1_2_R1.fq.gz
SAMN34331662	E177_14_10_1_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_10_1_2_R1.fq.gz
SAMN34331663	E177_14_10_1_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_10_1_2_R1.fq.gz
SAMN34331664	E177_14_10_1_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_10_1_2_R1.fq.gz
SAMN34331665	E177_14_10_1_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_10_1_2_R1.fq.gz
SAMN34331666	E177_14_10_1_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_10_1_2_R1.fq.gz
SAMN34331667	E177_14_10_1_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_10_1_2_R1.fq.gz
SAMN34331668	E177_14_10_1_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_10_1_2_R1.fq.gz
SAMN34331256	E177_14_10_1_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_10_1_2_R1.fq.gz
SAMN34331267	E177_14_10_1_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_10_1_2_R1.fq.gz
